ImmuCell Corporation Public Float
ImmuCell Corporation (ICCC) had Public Float of $50.60 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-05-13
- 2025-06-30: Entity Public Float $50.60M.
- 2025-06-27: Entity Public Float $50.60M.
- 2024-06-30: Entity Public Float $30.63M.
- 2023-06-30: Entity Public Float $31.16M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $50.60M 10-K · filed 2026-03-30 |
| 2025-06-27 | $50.60M 10-K/A · filed 2026-05-13 |
| 2024-06-30 | $30.63M 10-K · filed 2025-03-28 |
| 2023-06-30 | $31.16M 10-K · filed 2024-04-01 |
| 2022-06-30 | $64.44M 10-K · filed 2023-03-29 |
| 2021-06-30 | $64.21M 10-K · filed 2022-03-30 |
| 2020-06-30 | $29.52M 10-K · filed 2021-03-30 |
| 2019-06-30 | $40.67M 10-K · filed 2020-03-27 |
| 2018-06-30 | $31.53M 10-K · filed 2019-03-22 |
| 2017-06-30 | $29.18M 10-K · filed 2018-03-29 |
| 2016-06-30 | $22.87M 10-K · filed 2017-03-30 |
| 2015-06-30 | $17.15M 10-K · filed 2016-03-25 |
| 2014-06-30 | $9.58M 10-K · filed 2015-03-26 |
| 2013-06-28 | $8.31M 10-K · filed 2014-03-26 |
| 2012-06-29 | $12.93M 10-K · filed 2013-03-28 |
| 2011-06-30 | $17.30M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |